glp-1 for autoimmune disease Health Feed Association between autoimmune diseases and
Description
Its proven ability to aid weight loss has lately been popular among people to help fight obesity
GLP-1 reduces input
Specifically, among the 15,264 females on GLP-1 drugs, 1.62% were diagnosed with breast cancer during the study, compared to 2.47% of the 96,382 females who did not use GLP-1 medications
So whats going on
Nonetheless, some commercial mimics of GLP-1, such as Liraglutide, even when administered peripherally, appear to cross the BBB and activate neurons within the ARC resulting in GABA dependent inhibition of neuropeptide Y (NPY) and agouti-related peptide (AgRP) secretion
